DEFA14A: Sharps Technology Urges Shareholders to Vote for Reverse Stock Split to Maintain NASDAQ Listing

Sharps Technology is urging shareholders to vote in favor of a reverse stock split at the upcoming October 7, 2024 meeting to regain compliance with NASDAQ's minimum bid price requirement and avoid delisting.

Summary

• Sharps Technology is reminding shareholders to vote for a proposal to authorize a reverse stock split at the special shareholder meeting on October 7, 2024.
• The company needs the reverse stock split to regain compliance with NASDAQ's minimum bid price requirement of $1.00.
• The board recommends a reverse stock split range of 1-for-8 up to 1-for-22.
• Failure to approve the reverse stock split could result in delisting from NASDAQ, which could negatively impact the value and trading volume of the company's securities.
• Approval of the reverse stock split is expected to help maintain the company's stock volume and ease of trading, encourage investor interest, and allow for continued access to capital for growth strategies.
• Shareholders of record as of August 13, 2024, are entitled to vote.
• The company has partnered with Nephron Pharmaceuticals to expand its manufacturing capacity in the U.S.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the company is facing a challenge with NASDAQ compliance, they are taking proactive steps to address it. The outcome depends on shareholder approval and the effectiveness of the reverse stock split.

Positives

• Maintaining the NASDAQ listing is expected to help maintain the company's stock volume and ease of trading.
• A NASDAQ listing is expected to encourage investor interest and analyst coverage.
• The reverse stock split is expected to allow the company to continue to raise capital to pursue its growth strategies.

Negatives

• Failure to approve the reverse stock split could result in delisting from NASDAQ.
• Delisting from NASDAQ could adversely affect the value of the securities and decrease trading volume.
• Raising capital may be more challenging if the reverse stock split is not approved.

Risks

• The company faces the risk of delisting from NASDAQ if the reverse stock split is not approved.
• Delisting could negatively impact the value and liquidity of the company's stock.
• The company's ability to raise capital could be hindered if it is delisted.

Future Outlook

The company expects to continue to be able to raise capital to grow the Company following the reverse stock split.

Management Comments

• 'Please take a very important step to preserve your investment and to help ensure that Sharps Technology can continue to execute its business plan,' said Robert M. Hayes, Chief Executive Officer.
• Mr. Hayes stated that the Board of Directors has recommended and approved a further range for the reverse stock split of 1-for-8 up to 1-for-22 to provide the best opportunity to remain NASDAQ compliant in the long-term.

Industry Context

Reverse stock splits are a common mechanism used by companies to regain compliance with exchange listing requirements, particularly minimum bid price rules. Other companies in similar situations may also consider this strategy.

Comparison to Industry Standards

• Many companies facing delisting from major exchanges have implemented reverse stock splits, including companies like BioPharmX and Titan Machinery.
• The success of a reverse stock split in maintaining listing and improving stock price varies depending on the company's underlying financial health and market conditions.
• A 1-for-8 to 1-for-22 reverse split is within the typical range seen in similar situations, but the specific ratio needs to be sufficient to meet the $1.00 minimum bid price.

Stakeholder Impact

• Shareholders face the risk of decreased stock value and liquidity if the company is delisted.
• Employees may be affected by the company's ability to raise capital and execute its growth strategies.
• The company's customers and suppliers could be impacted by its financial stability and ability to operate effectively.

Next Steps

• Shareholders need to vote on the reverse stock split proposal before the October 7, 2024 meeting.
• The company will proceed with the reverse stock split if the proposal is approved.
• The company will need to demonstrate compliance with NASDAQ's minimum bid price requirement following the reverse stock split.

Key Dates

Keywords

reverse stock split, NASDAQ, shareholder meeting, delisting, minimum bid price, proxy vote, Sharps Technology, STSS